" class="no-js "lang="en-US"> Yoshinori Abe - Medtech Alert
Wednesday, July 23, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Yoshinori Abe

Yoshinori Abe

About Yoshinori Abe

Graduated from the Department of Medicine, University of Tokyo in 2015. Completed the initial training at the University of Tokyo Hospital and Tokyo Metropolitan Health and Longevity Medical Center.
Came to the world of data science when he met a patient who died at the age of 48 after leaving a bloody stool.

In May 2017, Co-founded Ubie Inc., together with his high school classmate Kubo Kouta, a software engineer. In an effort to reform the way people work in healthcare, the company will start offering a medical interview system using AI to medical institutions nationwide.

Since December 2019, he has been a member of the Emergency AI Research Promotion Special Committee of the Japanese Association for Acute Medicine.

In 2020, Selected in the Forbes 30 Under 30 Asia Healthcare & Science category.

Related Story

Artificial Intelligence

 Ubie

Ubie, Japanese Health-tech Startup, Raises $26.2 Million in Series C, $59.8 Million in Total

August 22 2022

Ubie, Inc., a healthcare AI startup with the mission “To develop a healthcare guide for everyone,” […]

Artificial Intelligence

 Ubie

Ubie, Japanese HealthTech Startup, Launches AI-powered Symptom Checker in U.S.

April 26 2022

Ubie, Inc., a healthcare AI startup with the mission “To develop a healthcare guide for […]